Bolt Medical’s Post

Is it feasible to develop and utilise standard lists of reasons for changes in participant involvement in trials? Great session on participant retention and follow up at #ICTMC2024 , including work by Will Cragg at Leeds Clinical Trials Research Unit (Leeds CTRU) reviewing case report forms from a range of clinical trials units (including MRC Clinical Trials Unit at UCL) to explore current practice for collecting data about participants changing their level of involvement in trials. #clinicaltrials #missingdata

#DidYouKnow WCG's Clinical Trial Listing Service (CTLS) has been connecting patients with relevant clinical trial options for over two decades? By aggregating trial data from both public and proprietary sources, WCG's CTLS offers the most comprehensive selection of clinical trials, empowering patients and their families to make informed decisions. As the trusted go-to resource, WCG's CTLS welcomes over 2 million unique visitors each year, providing hope and access to life-changing clinical trials. Learn more: https://lnkd.in/eagDmYSU #WCG #CTLS #clinicalresearch #clinicaltrial

Unlocking the potential of Risk-Based Monitoring (RBM) in clinical trials! Discover how ClinMax CRO's innovative strategies optimize trial efficiency, accelerate timelines, and enhance patient safety. Swipe to learn more! #RBM #Riskbasedmonitoring #ClinicalTrials #ClinicalResearch #ClinMax #MiddleEast #Africa

It's been great to lead on this report - the 2024 ABPI report on the status of UK industry clinical trials. While there are some welcome signs that delivery of industry clinical trials in the UK is improving there is clearly more progress to be made. We've made a series of six clear recommendations that would build on this momentum to further improve the UK competitiveness for industry clinical trials delivery.

The public consultation, the adoption of the revised CTIS transparency rules, the implementation in the system of the new features resulting in the launch of the new CTIS public portal today ! What an incredible journey leading to increased transparency for clinical trials in the EU.

Today is the day that the new transparency rules are live in CTIS. This is a step towards simplicity for sponsors and increased transparency for the public. Is your clinical trial transparency process CTIS ready? Holtzople Consulting can help you.

Sharing long term outcomes of RET Libretto001 trial in #lungcancer showing that there is a good track record of safety and managable AEs like HTN and LFT increases wiht selpercatinib. Good news for our patients https://lnkd.in/eNSaGsZU #MemorialCancerInstitute #MemorialHealthcareSystem #LCSM

A key change in the way patients, stakeholders and healthcare professionals access Clinical Trial Information was launched today! The Clinical Trials Information System #CTIS is another step forward for the Clinical Trial world; allowing earlier and more efficient access to information on potentially live saving clinical trials. #CTIS #Clinicaltrials #Clinicaltrialsupplies #CTS

Progress. We still have a long way to go to be as effective, inclusive and wide ranging as we're able to be. That change will include agility of trial units for variety of trials which can be considered, pace to open a trial to allow maximum time for UK participants to be recruited, capacity to offer the maximum number of patients the opportunity to participate, further streamlining of central processes and maintenance of costs to remain attractive to external trial sponsors while allowing investment to maintain trial unit competitive function.

Clinical trial sponsors are facing a critical challenge: prolonged trial timelines. The good news? Mobile visits reduce trial timelines. The latest data shows that studies incorporating mobile visits are up to 41% more likely to finish ahead of schedule compared to those without. Read more about the benefits of mobile visits in clinical trials here: https://lnkd.in/gbKhVBqv #MobileVisits #TrialEfficiency #ClinicalResearchAdvancement